Magnin

Haute Residence and Maxine & Marti Gellens Continue Their Real Estate Partnership Into Third Year

Retrieved on: 
Thursday, November 30, 2023
UCLA, Joseph Magnin, Real estate, Girl Scout Cookies, Magnin, Friends, Partnership, Residence, Houston Astros, San Diego Padres

LA JOLLA, Calif., Nov. 30, 2023 /PRNewswire-PRWeb/ -- MaxineBorn and raised in San Diego, Maxine has been selling all her life! Beginning with the top Girl Scout Cookie sales to selling the most clothes at Joseph Magnin to her 40 years in Real Estate, selling and helping others is her passion. She loves ballroom dancing, following her grandsons in all of their pursuits, and watching the Padres win or lose! Maxine has 2 children, Marti (her partner) and Andy, a physician, and 4 wonderful grandsons that keep her busy.

Key Points: 
  • Haute Residence and acclaimed real estate agents Maxine & Marti Gellens take their partnership into its third year.
  • As Haute Residence members, Maxine & Marti Gellens are two of the agents who exclusively represent the high-end real estate market in La Jolla, CA.
  • Marti began selling Real Estate in 1985 after graduating from UCLA with a degree in Kinesiology.
  • Visit Maxine & Marti Gellens' Haute Residence Profile: https://www.hauteresidence.com/member/maxine-marti-gellens/

Cognoa CEO and CMO Presenting at Digital Medicine & Medtech Showcase 2020 and InnovatorMD Global Summit in San Francisco

Retrieved on: 
Monday, January 6, 2020
Health, Articles, Health informatics, Medicine, Psychiatric diagnosis, Digital medicine, Pharmaceutical industry, Digital therapeutics, Autism, Magnin, Medication, Food and Drug Administration

Brent Vaughan, CEO and co-founder of Cognoa, will provide an update on the companys milestones and strategy at the Digital Medicine & Medtech Showcase 2020, to be held January 1315 in San Francisco.

Key Points: 
  • Brent Vaughan, CEO and co-founder of Cognoa, will provide an update on the companys milestones and strategy at the Digital Medicine & Medtech Showcase 2020, to be held January 1315 in San Francisco.
  • The Company presentation is scheduled for Tuesday, January 14 at 10:45 a.m. PT at the Parc 55 Hilton Hotel, 55 Cyril Magnin Street.
  • Cognoa is advancing the standard of pediatric behavioral healthcare with digital therapeutics and medicines that enable earlier identification, diagnosis and treatment for improved lifelong outcomes.
  • Our lead prescription products, the first digital diagnostic aid and the first prescription digital therapeutic for autism, have both received Breakthrough Device designation from the FDA.